, Volume 25, Supplement 2, pp 1–4 | Cite as

The Present and Future Use of β-Blockers

  • N. M. Kaplan
Section 1A: Hypertension


The current state of knowledge about β-blockers in treating hypertension and their comparative pharmacology is reviewed. Some new developments in antihypertensive therapy, such as converting-enzyme inhibitors and calcium antagonistic drugs are discussed and their place vis-a-vis the β-blockers analysed.


Captopril Atenolol Calcium Antagonist Oxprenolol Lipid Solubility 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barbarino, A. and De Marinis, L.: Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects. Journal of Clinical Endocrinology and Metabolism 51: 749–754 (1980).PubMedCrossRefGoogle Scholar
  2. Bühler, F.R.; Burkhart, F.; Lutold, B.E.; Kung, M.; Marbet, G. and Pfisterer, M.: Antihypertensive beta-blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. American Journal of Cardiology 35: 653–669 (1975).CrossRefGoogle Scholar
  3. Campbell, W.B.; Johnson, A.R.; Callahan, K.S. and Graham, R.M.: Anti-platelet activity of beta-adrenergic antagonists: Inhibition of thromboxane synthesis and platelet aggregation in patients receiving long-term propranolol treatment. Lancet 2: 1382–1384 (1981).PubMedCrossRefGoogle Scholar
  4. Day, J.L.; Metcalfe, J. and Simpson, C.N.: Adrenergic mechanisms in control of plasma lipid concentrations. British Medical Journal 284, 1145–1148 (1982).PubMedCrossRefGoogle Scholar
  5. Guazzi, M.; Olivari, M.T.; Polese, A.; Fiorentini, C.; Magrini, F. and Moruzzi, P.: Nifedipine, a new antihypertensive with rapid action. Clinical Pharmacology and Therapeutics 22: 528–532 (1977).PubMedGoogle Scholar
  6. Jennings, G.L.; Esler, M.D. and Korner, P.I.: Effect of prolonged treatment on hemodynamics of essential hypertension before and after autonomic block. Lancet 2: 166–169 (1980).PubMedCrossRefGoogle Scholar
  7. Kaplan, N.M.: Clinical Hypertension (3rd ed.) pp. 98–192 (Williams and Wilkins, Baltimore 1982).Google Scholar
  8. Lindemann, J.P.; Bailey, J.C. and Watanabe, A.M.: Potential biochemical mechanisms for regulation of the slow inward current: Theoretical basis for drug action. American Heart Journal 103: 746–755 (1982).PubMedCrossRefGoogle Scholar
  9. Lund-Johansen, P.: Hemodynamic consequences of long-term beta-blocker therapy: A 5-year follow-up study of atenolol. Journal of Cardiovascular Pharmacology 1: 487–495 (1979).PubMedCrossRefGoogle Scholar
  10. Meier, J.: Beta-adrenoceptor-blocking agents: Pharmacokinetic differences and their clinical implications illustrated on pindolol. Cardiology 64(Suppl. 1): 1–13 (1979).PubMedCrossRefGoogle Scholar
  11. Rubin, R.P.: Actions of calcium antagonists of secretory cells: in Weiss, G.B. (Ed.) New Perspectives on Calcium Antagonists, pp. 147–158 (American Physiology Society, Bethesda, Maryland 1981).Google Scholar
  12. Seedat, Y.K.: Trial of atenolol and chlorthalidone for hypertension in black South Africans. British Medical Journal 281: 1241–1245 (1980).PubMedCrossRefGoogle Scholar
  13. Swales, J.D.; Bing, R.G.; Heagerty, A.; Pohl, J.E.F.; Russell, G.I. and Thurston, H.: Treatment of refractory hypertension. Lancet 1: 894–896 (1982).PubMedCrossRefGoogle Scholar
  14. Watson, R.D.S.; Stallard, T.J. and Littler, W.A.: Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet 1: 1210–1213 (1979).PubMedCrossRefGoogle Scholar
  15. Wilcox, R.G.: Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension. British Medical Journal 2: 383–385 (1978).PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Australasia Pty Ltd (Inc. NSW) 1983

Authors and Affiliations

  • N. M. Kaplan
    • 1
  1. 1.Department of Internal MedicineUniversity of Texas Health Science Center, Southwestern Medical SchoolDallasUSA

Personalised recommendations